Luminor 35

BALLOON CATHETER

OVERVIEW

Paclitaxel drug-eluting balloon catheter designed for percutaneous transluminal angioplasty (PTA) of peripheral arteries (iliac, femoral, iliac-femoral segment, popliteal, tibial and renal arteries), and for treatment of obstructive lesions of native or synthetic arteriovenous fistulas.

CLINICAL STUDIES

Luminor has demonstrated its safety and efficacy in long-term follow-up and for various indications:

EffPac Trial

Multicenter, randomized and controlled trial, Luminor vs POBA.

82.10% fTLR

at 5 years

Learn More

MERLION Trial

Prospective, multicenter trial, with Luminor and Angiolite BTK as bailout stenting in BTK.

81.6% fTLR

at 1 year

Learn More

BIBLIOS Trial

Prospective, single-arm, multicentre study to evaluate the efficacy and safety of BTK treatment

86.6% fTLR

at 1 year

Learn More

SPECIFICATIONS

Diameter: 5, 6, 7 mm
Length: 20, 40, 60, 80, 120, 150 mm
OTW Delivery System Catheter
Working Length of Catheter: 80 cm and 140 cm
Guidewire Compatibility: 0.035’’
Tip Profile: 0.036’’
Crossing Profile: от 0.065’’ до 0.077’’
Nominal Pressure: 6/7 atm
Rated Burst Pressure (RBP): 16 atm
Average Burst Pressure (ABP): 23 atm

RESOURCES

Registration Certificate

Luminor 35 Brochure